Literature DB >> 28699521

Astrocyte: An Innovative Approach for Alzheimer's Disease Therapy.

Maria R Bronzuoli1, Roberta Facchinetti1, Luca Steardo1, Caterina Scuderi1.   

Abstract

Alzheimer's disease (AD) is a devastating neurological illness with a heavy economic impact. Further comorbidities in combination with the social impact of this disorder increase the urgency of a clearer comprehension of its etiopathogenesis, allowing the execution of novel therapeutic strategies. Despite astrocytes have been widely described as active participant in the regulation of cerebral circuits, available data are still poor. Even less information is available about their precise role in the pathogenesis of illness. Moreover, the scant knowledge about the astrocyte-neuron interplay in health and disease still impedes pioneering discoveries. The focus of this review is to look for new and innovative pharmacological approaches against AD. In order to perform this, we used the following keywords in PubMed search engine: astrocytes, therapy, Alzheimer's disease, and glia in different combinations. With this review, we collected data available in literature describing how also astrocytes besides neurons might be new potential targets for drug discovery. Different approaches currently being studied include modulation of glutamate transporters expression, astroglial genetic manipulation, free radicals inhibition, up-regulation of neurotrophins, and regulation of astrogliosis and neuroinflammation. Since several studies already demonstrated that astrocytes are definitely involved in AD pathogenesis, these cells can represent a promising new therapeutic target. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer's disease; Astrocytes; genetic manipulation; neurotrophins; pharmacotherapy; reactive gliosis

Mesh:

Substances:

Year:  2017        PMID: 28699521     DOI: 10.2174/1381612823666170710163411

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer's Disease.

Authors:  Roberta Facchinetti; Marta Valenza; Chiara Gomiero; Giulia Federica Mancini; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Biomedicines       Date:  2022-05-26

2.  Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease.

Authors:  Benoit de Pins; Carmen Cifuentes-Díaz; Amel Thamila Farah; Laura López-Molina; Enrica Montalban; Anna Sancho-Balsells; Ana López; Silvia Ginés; José María Delgado-García; Jordi Alberch; Agnès Gruart; Jean-Antoine Girault; Albert Giralt
Journal:  J Neurosci       Date:  2019-01-30       Impact factor: 6.167

3.  Neuroprotective Effects and Mechanism of β-Asarone against Aβ1-42-Induced Injury in Astrocytes.

Authors:  Yuanxiao Yang; Ling Xuan; Hongshu Chen; Shijie Dai; Liting Ji; Yuting Bao; Changyu Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-28       Impact factor: 2.629

4.  Looking for a Treatment for the Early Stage of Alzheimer's Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin.

Authors:  Roberta Facchinetti; Marta Valenza; Maria Rosanna Bronzuoli; Giorgia Menegoni; Patrizia Ratano; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

5.  Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease.

Authors:  Sarah Beggiato; Maria Cristina Tomasini; Tommaso Cassano; Luca Ferraro
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

6.  Structural characterization and anti-oxidation activity evaluation of pectin from Lonicera japonica Thunb.

Authors:  Xiaodan Qi; Yang Yu; Xinyi Wang; Jialei Xu; Xiang Wang; Zhangkai Feng; Yifa Zhou; Hongxing Xiao; Lin Sun
Journal:  Front Nutr       Date:  2022-09-20

7.  Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome.

Authors:  Theodora Panagaki; Laura Lozano-Montes; Lucia Janickova; Karim Zuhra; Marcell P Szabo; Tomas Majtan; Gregor Rainer; Damien Maréchal; Yann Herault; Csaba Szabo
Journal:  Redox Biol       Date:  2022-01-13       Impact factor: 10.787

8.  Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.

Authors:  Caterina Scuderi; Maria Rosanna Bronzuoli; Roberta Facchinetti; Lorenzo Pace; Luca Ferraro; Kevin Donald Broad; Gaetano Serviddio; Francesco Bellanti; Gianmauro Palombelli; Giulia Carpinelli; Rossella Canese; Silvana Gaetani; Luca Steardo; Luca Steardo; Tommaso Cassano
Journal:  Transl Psychiatry       Date:  2018-01-31       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.